Why Gene Therapy Is The Best Bet For Restoring Functional Vision

By: via Benzinga
Shares of Spark Therapeutics Inc (NASDAQ: ONCE) are up more than 35 percent since its IPO in late January. The company is engaged in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.